Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development

Vitality Biopharma Inc (OTCMKTS:VBIO) ended 2016 on a happy note by announcing approvals from two regulators for expanding development activities for novel cannabinoid pharmaceutical prodrugs. The company said that both the State of California Research Advisory Panel, as well as, the U.S. Drug Enforcement Agency (DEA) has given their nods for expanding activities of expansion […]

Vitality Biopharma Inc (OTCMKTS:VBIO) Has Targeted Prodrug Delivery Technique

Vitality Biopharma Inc (OTCMKTS:VBIO) uses its proprietary cannaboside prodrug, which enables it to deliver a specific and targeted dose of its CBD compound. In prior, non-related trials, cannabinoids have shown the ability to effectively cure Crohn’s disease patients, with more than 40% of the subjects having had the ailment put into remission. These previous results, […]